Skip to content

Clinical trials

Phase 3 Candidiasis trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Candidiasis Phase: Phase 3 Clear all

25 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20011
20033
20044
20082
20093
20101
20121
20131
20181
20191
20201

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed18
Terminated5
Unknown status2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Pfizer6
National Cancer Institute (NCI)4
Astellas Pharma Inc2
Merck Sharp & Dohme LLC2
National Institute of Allergy and Infectious Diseases (NIAID)2
Astellas Pharma Global Development, Inc.1
Centre Hospitalier Universitaire, Amiens1
Cidara Therapeutics Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)1
Daniel Benjamin1
Janssen Pharmaceutical K.K.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Candidiasis25
Mycoses13
Candidemia8
Fungemia6
Aspergillosis5
Candidiasis, Invasive5
Invasive Fungal Infections4
Cryptococcosis3
Acquired Immunodeficiency Syndrome2
HIV Infections2

Trials

Showing 51 to 25 of 25. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.